UroSure Wholesale
For Healthcare Professional Use Only.
Solutions / FQHCs and Community Health Centers

Same-visit STI screening for FQHC budgets and FQHC patients.

Wholesale pricing scoped to HRSA grant budgets, single-visit workflow that survives the transportation barriers FQHC patients face, and reporting compatibility with HEDIS and UDS.

UroSure point-of-care urine test kit
FIG. 01 — UroSure kit
The problem

Loss-to-follow-up is the program metric.

FQHCs and look-alikes serve patient populations where transportation, work schedules, and housing instability make the second visit a real obstacle. If a positive screening result arrives after the patient is gone, the program loses both the patient outcome and the HEDIS/UDS completion line.

  • 01 Patients face transportation, scheduling, and follow-up barriers that make second-visit return rates structurally lower than other settings.
  • 02 340B and HRSA grant budgets demand a low and predictable cost-per-result; per-CPT send-out unpredictability erodes program economics.
  • 03 Loss-to-follow-up on positive screening results is one of the most-watched UDS metrics — and one of the hardest to move without a workflow change.
  • 04 Mobile, outreach, and Title X clinics often operate outside a fixed lab-courier loop, making send-out NAAT logistically painful.
UroSure fit

A wholesale price built around grant budgets.

UroSure is priced and configured for the FQHC/HRSA buyer. Wholesale tiers fit Title X and Section 330 budgets. The single-visit workflow keeps screening completion inside one encounter, which supports the HEDIS and UDS lines most program managers care about.

01

Fit

  • Same-visit result closes the screening loop in one encounter, removing the follow-up step that drives FQHC loss-to-follow-up metrics.
  • Wholesale per-kit pricing fits HRSA grant and Title X budgets with Net-30/Net-60 invoicing available on approved credit.
  • Single-specimen workflow extends naturally to mobile and outreach clinics where multi-specimen NAAT logistics break down.
  • Supports HEDIS and UDS reporting on STI-screening completion by capturing the result inside the encounter that initiated screening.
02

Use cases

  • Annual STI screening for sexually active patients during regular primary-care visits.
  • Title X family-planning encounters where same-visit screening is a program objective.
  • Mobile and outreach clinics serving rural, migrant, or unhoused populations.
  • Look-alike sites under HRSA Section 330 needing predictable per-test costs.
03

Economics

  • Net-30 and Net-60 invoicing available for grant-funded buyers on approved credit.
  • Volume tier pricing at 1, 5, 25, and 100+ cases for multi-site networks.
  • 340B Drug Pricing Program qualification — TBD: client confirms eligibility.
  • Compatible with the funding sources listed on the Solutions Hub (Title X, Ryan White Part C, CDC PS21-2102, SAMHSA, state/county contracts).
Common questions

FQHCs and Community Health Centers, in detail.

01 Does UroSure qualify for 340B drug pricing?
TBD — the client confirms 340B status and any program-specific restrictions. UroSure is a diagnostic device, not a drug; consult your 340B coordinator for applicability.
02 Is wholesale pricing compatible with Title X budgets?
Yes. Wholesale pricing is structured with grant-funded budgets in mind. Specific tier values are scoped to your monthly volume — email sales@urosurewholesale.com with your patient panel size for a quote.
03 Can UroSure be deployed in mobile and outreach clinics?
TBD — the client confirms portable storage and deployment guidance for mobile and non-fixed-site use, including lot-traceability for field deployments.
04 How does this map to HEDIS and UDS reporting?
Same-visit result capture keeps screening completion inside one encounter, which is the simplest path to HEDIS chlamydia-screening completion and UDS Table 6B sexual-health metrics. Final reporting workflow remains the clinic's responsibility.
05 What's the procurement workflow for federal and state buyers?
SAM.gov registration with CAGE/UEI on file, W-9 available on request, and GPO contract status (TBD: client populates) for federal and state buyers. Distributor relationships are listed on the Solutions Hub.
Next step

Bring UroSure to your practice.

Order a paid five-pack sample, or request a wholesale pricing quote sized for your practice.